Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Other Non Operating Income (2018 - 2025)

Bioadaptives' Other Non Operating Income history spans 7 years, with the latest figure at $32100.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to $32100.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $307117.0, a 216.94% increase, with the full-year FY2025 number at $133800.0, changed N/A from a year prior.
  • Other Non Operating Income hit $32100.0 in Q4 2025 for Bioadaptives, down from $101700.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for BDPT hit a ceiling of $138337.0 in Q3 2021 and a floor of -$316056.0 in Q4 2023.
  • Historically, Other Non Operating Income has averaged -$40055.9 across 5 years, with a median of -$5067.0 in 2022.
  • Biggest five-year swings in Other Non Operating Income: tumbled 604.66% in 2023 and later soared 234.72% in 2025.
  • Tracing BDPT's Other Non Operating Income over 5 years: stood at $94201.0 in 2021, then crashed by 105.38% to -$5067.0 in 2022, then crashed by 6137.54% to -$316056.0 in 2023, then skyrocketed by 126.67% to $84292.0 in 2024, then tumbled by 61.92% to $32100.0 in 2025.
  • Business Quant data shows Other Non Operating Income for BDPT at $32100.0 in Q4 2025, $101700.0 in Q3 2025, and $121305.0 in Q2 2025.